Global Enteral Feeding Formulas Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 3.56 Billion |
 Market Size (Forecast Year) |
USD 6.20 Billion |
 CAGR |
% |
| Major Markets Players |
|
>全球肠内喂养配方市场，按产品（糖尿病配方、肝配方、肾配方、肽基配方、标准配方、疾病特异性配方、混合配方、元素配方、半元素配方、聚合物配方、水解配方、纤维补充配方等）、应用（肿瘤科、神经科、重症监护、糖尿病、胃肠病学等）、管饲类型（胃管饲、鼻胃管饲、胃造口管饲和十二指肠或空肠管饲）、阶段（成人和儿科）、最终用户（医院、家庭护理、疗养院、辅助生活设施和长期护理设施）、口味类型（有味和无味）、给药方式（口服、胃和经幽门）、形式（粉末、液体等）、分销渠道（网上销售、零售销售、和机构销售）、流动类型（间歇进料流和连续进料流）– 行业趋势和预测到 2031 年。
肠内喂养配方市场分析及规模
肠内喂养配方市场发展迅速，这得益于配方和给药技术的创新。最新方法包括基于肽和针对特定疾病的配方，可增强营养吸收和患者治疗效果。慢性病患病率上升和人口老龄化推动了增长，智能泵和实时监控提高了临床和家庭环境中的效率和安全性。
2023 年全球肠内喂养配方奶粉市场规模为 35.6 亿美元，预计到 2031 年将达到 62 亿美元，预测期内（2024 年至 2031 年）的复合年增长率为 7.20%。这表明市场价值。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022 (可定制为 2016-2021) |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
Product (Diabetic Formulas, Hepatic Formulas, Renal Formulas, Peptide Based Formulas, Standard Formulas, Disease-Specific Formulas, Blenderized Formula, Elemental Formula, Semi-elemental Formula, Polymeric Formula, Hydrolysed Formula, Fibre-supplemented Formula, and Others), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology and Others) Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding and Duodenal or Jejunal Tube Feeding), Stage (Adult and Paediatric), End User (Hospitals, Home Care, Assisted Living Facilities, Nursing Homes, and Long Term Care Facilities), Flavor Type (Flavored and Unflavored), Mode of Delivery (Oral, Gastric, and Trans-pyloric), Form (Powder, Liquid, and Others), Distribution Channel (Online Sales, Retail Sales, and Institutional Sales), Flow Type (Intermittent Feeding Flow and Continuous Feeding Flow) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Hormel Foods Corporation (U.S.), Global Health Products, Inc. (U.S.), Medline Industries, Inc. (U.S.), Mead Johnson & Company, LLC (U.S.), Medtrition Inc. (U.S.), Nutritional Medicinals, LLC (U.S.), Real Food Blends (U.S.), Meiji Holdings Co., Ltd. (Japan), Fresenius Kabi AG (Germany), B. Braun SE (Germany), and Abbott (U.S.) |
|
Market Opportunities |
|
Market Definition
Enteral feeding formula is a nutritionally balanced liquid diet delivered directly to the gastrointestinal tract through a tube. It is used for individuals unable to consume food orally, providing essential nutrients, including proteins, fats, carbohydrates, vitamins, and minerals. Formulas vary based on specific medical needs and digestive capabilities, ensuring adequate nutrition and hydration for patients.
Enteral Feeding Formula Market Dynamics
Drivers
- Increasing Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases such as cancer, diabetes, and gastrointestinal disorders drives the demand for enteral feeding formulas. For instance, cancer patients undergoing chemotherapy often experience severe nausea and appetite loss, making it difficult to maintain adequate nutrition through regular food intake. Enteral feeding formulas provide essential nutrients, supporting patient recovery and overall health, thereby fueling market growth.
- Growing Incidence of Swallowing Disorders
The growing incidence of swallowing disorders, such as dysphagia, significantly drives the enteral feeding formula market. Both elderly patients and younger individuals with conditions such as stroke, Parkinson's disease, or neurological impairments often require enteral feeding for proper nutrition. For instance, a stroke patient with severe dysphagia might rely on enteral tube feeding formulas to meet their nutritional needs, thus fueling the demand for these specialized products.
Opportunities
- Rising Home Healthcare Growth
The growth of home healthcare services is significantly boosting the market for home-based enteral nutrition products. This trend allows patients with chronic conditions or those recovering from surgeries to receive essential nutritional support in the comfort of their homes. For instance, elderly individuals recovering from gastrointestinal surgeries can now maintain their nutritional intake effectively with specialized enteral feeding formulas, driving demand and innovation in this sector.
- Rising Nutritional Management of Cancer Patients
Enteral feeding plays a crucial role in managing nutrition for cancer patients undergoing chemotherapy or radiotherapy, who often face challenges in consuming sufficient regular meals due to treatment side effects. For instance, patients with head and neck cancers may experience swallowing difficulties (dysphagia), making enteral feeding via feeding tubes essential for maintaining adequate nutrition levels. This necessity significantly drives the demand for enteral feeding formulas tailored to meet the nutritional needs of cancer patients.
Restraints/Challenges
- Risk of Contamination
The risk of contamination in enteral feeding formulas, if mishandled during production or administration, poses a significant barrier to market acceptance. Strict adherence to hygiene standards is crucial to mitigate this risk, as any compromise can lead to adverse health effects for patients, eroding trust and adoption in the market.
- Preference for Parenteral Nutrition
Preference for parenteral nutrition over enteral feeding formulas among healthcare providers and patients can hinder market demand due to perceived advantages such as bypassing gastrointestinal issues and ensuring precise nutrient delivery. This preference stems from clinical considerations despite potential drawbacks such as increased infection risks and higher costs associated with parenteral administration.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In September 2023, Abbott announced plans to expand manufacturing of various adult enteral formulas for the retail market, aiming to address shortages in the institutional sector by boosting production capacity and distribution channels
- In 2023, Nestlé and EraCal Therapeutics commenced a collaborative research venture aimed at discovering novel nutraceuticals tailored to regulate food intake. This partnership seeks to leverage their respective expertise to develop innovative solutions that address consumer needs for effective dietary management
- In September 2022, Kate Farms secured USD 75 million in a Series C funding round led by Novo Holdings, enhancing efforts in plant-based clinical nutrition research, product innovation, and expansion across diverse market segments
- In September 2022, Kate Farms introduced Adult Standard 1.4, a high-calorie medical formula now available in chocolate, designed to support weight gain, maintenance, and digestive tolerance while offering a palatable flavor option for consumers
Enteral Feeding Formula Market Scope
The market is segmented on the basis of product, application, type of tube feeding, stage, flavor type, mode of delivery, form, distribution channel, flow type, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Diabetic Formulas
- Hepatic Formulas
- Renal Formulas
- Peptide Based Formulas
- Standard Formulas
- Disease-Specific Formulas
- Alzheimer’s
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Malabsorption/GI Disorder/Diarrhea
- Others
- Blenderized Formula
- Elemental Formula
- Semi-elemental Formula
- Polymeric Formula
- Hydrolysed Formula
- Fibre-supplemented Formula
- Others
Application
- Oncology
- Neurology
- Critical Care
- Diabetes
- Gastroenterology
- Others
Type of Tube Feeding
- Gastric Tube Feeding
- Nasogastric Tube Feeding
- Gastrostomy Tube Feeding
- Duodenal or Jejunal Tube Feeding
Stage
- Adult
- Paediatric
End User
- Hospitals
- Home Care
- Nursing Homes
- Assisted Living Facilities
- Long Term Care Facilities
Flavor Type
- Flavored
- Vanilla
- Strawberry
- Butter Pecan
- Others
- Unflavored
Mode of Delivery
- Oral
- Gastric
- Nasogastric
- Oro-gastric
- Gastronomy
- 经幽门
- 鼻空肠
- 胃空肠造口术
- 空肠造口术
形式
- 粉末
- 液体
- 其他的
分销渠道
- 网上销售
- 零售销售
- 机构销售
流程类型
- 间歇供料流程
- 连续进料流
肠内喂养配方市场区域分析/见解
对市场进行分析，并按国家、产品、应用、管饲类型、阶段、风味类型、交付方式、形式、分销渠道、流程类型和最终用户提供市场规模洞察和趋势。
市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区（APAC）的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区（APAC）的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲（MEA）的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
预计亚太地区肠内喂养配方奶粉市场在预测期内将出现显著增长，这得益于该地区肠内喂养配方奶粉种类的丰富以及早产率的上升。这一趋势凸显了对支持新生儿健康和发育的专业营养解决方案的需求日益增长。
由于癌症、糖尿病和神经系统疾病等慢性疾病的发病率较高，北美预计将主导肠内营养配方奶粉市场。这一人口结构推动了对专业营养支持的需求，从而推动了该地区的市场增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及由于来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
该市场还为您提供每个国家/地区资本设备医疗支出增长、市场上不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对市场的影响的详细市场分析。数据适用于 2016-2021 年的历史时期。
竞争格局和肠内喂养配方市场份额分析
市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
市场上的一些主要参与者包括：
- 荷美尔食品公司（美国）
- 全球健康产品公司（美国）
- Medline Industries, Inc.（美国）
- 美赞臣公司（Mead Johnson & Company, LLC.）（美国）
- Medtrition Inc.（美国）
- 营养药品有限责任公司（美国）
- 真正的食物混合物（美国）
- 明治控股株式会社（日本）
- 费森尤斯卡比公司（德国）
- B. Braun SE（德国）
- 雅培（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
